Context Partners Fund’s Strata Critical Medical Inc SRTA Stock Holding History

Context Partners Fund’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.78M	Buy	+176,984	New	+$1.79M	0.39%	71

Other funds holding SRTA

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Context Partners Fund's SRTA Position: Q3 2020 in Review

Context Partners Fund opened a new position in Strata Critical Medical Inc (SRTA) in Q3 2020: 176,984 shares worth $1.78M. The stake represents 0.39% of the portfolio and ranks #71 among its holdings.

58 funds tracked by Wall St. Rank hold SRTA as of Q3 2020.

Context Partners Fund held 176,984 shares of Strata Critical Medical Inc worth $1.78M as of Q3 2020.
Strata Critical Medical Inc was a new Context Partners Fund position in Q3 2020.
Strata Critical Medical Inc made up 0.39% of Context Partners Fund's portfolio in Q3 2020, its #71 holding.
58 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2020.

Based on Context Partners Fund's 13F filing for Q3 2020, filed 16 Nov 2020.